Skip to content
Sign In

Main Navigation

James Sharp Logo
  • Individuals
    Individuals

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service
  • Charities & Trustees
    Charities & Trustees

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • Companies
    Companies

    Choose Your Level of Service

    • Discretionary ServiceDiscretionary Service
    • Execution Only ServiceExecution Only Service

  • News & Insights
    • News & Insights
    • Current Research Coverage List
  • About Us
    • About Us
    • Our People
  • Conectus Portal
  • Contact Us

Market News - Page 333

6 July 2022

Assura plc Holdings in Company- Notification of Major Holding

TR-1: Standard form for notification of major holdings…

6 July 2022

Assura plc Trading Update for First Quarter 2022

Assura plc (“Assura”), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2022….

6 July 2022

Pressure Technologies plc Investor Presentation

Pressure Technologies (AIM: PRES), the specialist engineering group, is pleased to announce that Chris Walters, Chief Executive and James Locking, Chief Financial Officer will provide a live presentation relating to the Group's 2022 Interim Results via the Investor Meet Company platform on 20th July 2022 at 10:00am BST….

6 July 2022

Advanced Medical Solutions Half-Year Trading Update

Advanced Medical Solutions Group plc (AIM: AMS), the world-leading specialist in tissue-healing technologies, today announces its unaudited trading update for the six months ended 30 June 2022 (the “Period”). The Group expects to announce its interim results on Wednesday 14th September 2022. …

5 July 2022

R.E.A Holdings plc Appointment of Director

The directors are pleased to announce that Mieke Djalil has been appointed as a non-executive director of REA with effect from 4 July 2022. …

5 July 2022

Pressure Technologies Sale and Leaseback of Roota Engineering Property

Pressure Technologies (AIM: PRES), the specialist engineering group, is pleased to announce that it has completed a sale and leaseback of its freehold property occupied by Roota Engineering in Rotherham with Victoria Court Mews Limited. …

5 July 2022

AstraZeneca plc to Acquire TeneoTwo and T Cell Engager

AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline…

4 July 2022

Hipgnosis Songs Fund Impact of Copyright Royalty Board III Decision

The Board of Hipgnosis Songs Fund Limited, the first UK listed investment company offering investors a pure-play exposure to songs and associated intellectual property rights, and its Investment Adviser, Hipgnosis Song Management Limited, welcome the decision of the US Copyright Royalty Board (CRB) to disallow the appeal by various streaming services against the CRB III determination to increase mechanical streaming royalty rates for songwriters and publishers….

Posts navigation

  • «
  • 1
  • …
  • 331
  • 332
  • 333
  • 334
  • 335
  • …
  • 919
  • »

Home > Market News > Page 333

James Sharp white Logo
Sign In
Linkedin Icon

The Exchange
5 Bank Street
Bury, Lancashire
BL9 0DN

Tel: 0161 764 4043

Fax: 0161 764 1628

Email: mail@jamessharp.co.uk

Linkedin Icon

James Sharp & Co is a trading name
of James Sharp & Co LLP (0C422665)

Members of the LLP are referred to as Partners

  • Downloads & Resources
  • Complaints
  • Financial Compensation Scheme
  • Conectus Portal

  • Cyber Essentials Certification
  • Website Terms & Conditions
  • Data Privacy Policy
  • Cookie policy
  • Consent Preferences

Email Newsletter Sign-up

Consent(Required)
What we do with you information. Find out more

© Copyright 2010-2026. All rights reserved. James Sharp & Co. Authorised & Regulated by the Financial Conduct Authority
Member of the London Stock Exchange - Member of the Aquis Stock Exchange - Member of PIMFA

Website by ICG